Cargando…

p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis

BACKGROUND: Published studies have yielded inconsistent results on the relationship between p53 status and the progression of stage T1 non-muscle invasive bladder cancer (NMIBC). Therefore, we performed a meta-analysis to evaluate the prognostic value of p53 in T1 NMIBC. METHODS: We systematically s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Jun, Wang, Shu-hua, Yang, Qing, Chen, Qian-qian, Yao, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851770/ https://www.ncbi.nlm.nih.gov/pubmed/27129876 http://dx.doi.org/10.1186/s12957-016-0890-9

Ejemplares similares

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.
por: Soini, Y., et al.
Publicado: (1993)

p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette–Guérin: A Meta-Analysis
por: Zhou, Xiaofeng, et al.
Publicado: (2015)

Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression
por: Wu, Ziyu, et al.
Publicado: (2017)

Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma
por: Ponnaboina, Divya Madhuri, et al.
Publicado: (2023)

p53 codon 72 polymorphism as a progression index for bladder cancer
por: LIN, HUNG-YU, et al.
Publicado: (2011)

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004)

p53 mutations have no additional prognostic value over stage in bladder cancer.
por: Vet, J. A., et al.
Publicado: (1994)

JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer
por: Pan, Chun-Wu, et al.
Publicado: (2016)

A Light-Inducible Split-dCas9 System for Inhibiting the Progression of Bladder Cancer Cells by Activating p53 and E-cadherin
por: Huang, Xinbo, et al.
Publicado: (2021)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Stage-specific sensitivity to p53 restoration during lung cancer progression
por: Feldser, David M., et al.
Publicado: (2010)

The dual role of p62 in ferroptosis of glioblastoma according to p53 status
por: Yuan, Fanen, et al.
Publicado: (2022)

Association Between BRCA Status and P53 Status in Breast Cancer: A Meta-Analysis
por: Peng, Lin, et al.
Publicado: (2016)

TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status
por: Zhang, Lei, et al.
Publicado: (2018)

The ARTS of p53-dependent mitochondrial apoptosis
por: Hao, Qian, et al.
Publicado: (2022)

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
por: Olsson, Hans, et al.
Publicado: (2013)

GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner
por: Lin, Fen, et al.
Publicado: (2019)

Mutant p53 in cancer therapy—the barrier or the path
por: Zhou, Xiang, et al.
Publicado: (2018)

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma
por: Boldrin, Elisa, et al.
Publicado: (2023)

p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression
por: Piaton, E, et al.
Publicado: (2005)

Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence
por: Ziaran, Stanislav, et al.
Publicado: (2020)

Deletions of 9p21 and TP53 in bladder cancer.
por: Park, W. S., et al.
Publicado: (1996)

BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma
por: Chen, Chang-Long, et al.
Publicado: (2021)

Mutant p53 in Cancer Progression and Targeted Therapies
por: Zhu, Gaoyang, et al.
Publicado: (2020)

Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
por: Vetterlein, Malte W., et al.
Publicado: (2017)

circNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis
por: Chen, Liang, et al.
Publicado: (2021)

Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer
por: Saavedra, Kathleen, et al.
Publicado: (2015)

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67
por: Tut, V M, et al.
Publicado: (2001)

p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
por: Busby-Earle, R. M., et al.
Publicado: (1994)

Role of p53 in breast cancer progression: An insight into p53 targeted therapy
por: Marvalim, Charlie, et al.
Publicado: (2023)

Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines
por: Yang, Chao, et al.
Publicado: (2016)

A CRISPR/dCasX‐mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c‐MYC or activating TP53
por: Cao, Congcong, et al.
Publicado: (2021)

Significance of TP53 mutation in bladder cancer disease progression and drug selection
por: Wu, Guang, et al.
Publicado: (2019)

p53 and Beta-Catenin Expression in Gallbladder Tissues and Correlation with Tumor Progression in Gallbladder Cancer
por: Ghosh, Mila, et al.
Publicado: (2013)

Knockdown of GNL3L Alleviates the Progression of COPD Through Inhibiting the ATM/p53 Pathway
por: Cai, Qian, et al.
Publicado: (2023)

Cigarette smoking and p53 mutations in lung cancer and bladder cancer.
por: Husgafvel-Pursiainen, K, et al.
Publicado: (1996)

The Potential Value of EGFR and P53 Immunostaining in Tumors of the Urinary Bladder
por: Ibrahim, N, et al.
Publicado: (2009)

Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis
por: Iwahashi, Naoyuki, et al.
Publicado: (2022)

p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer
por: Phillips, H A, et al.
Publicado: (2000)

The heme–p53 interaction: Linking iron metabolism to p53 signaling and tumorigenesis
por: Shen, Jia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oqm51r77c41dmp57irqoevirh9